Skip to content
10-Q

Quarterly Report

Gala Pharmaceutical Inc.

0001683168-18-003151

← back to feed
Filed
Oct 26, 2018 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Oct 22, 2018 78.95M sh
Capex Q3 2018 · Aug 31, 2018 $0
Capex Q3 2018 · Aug 31, 2017 $100K
Operating Cash Flow Q3 2018 · Aug 31, 2018 −$343.15K
Operating Cash Flow Q3 2018 · Aug 31, 2017 −$225.67K
Cash And Equivalents Q3 2018 · Aug 31, 2018 $14.62K
Cash And Equivalents Q3 2018 · Nov 30, 2017 $7.77K
Cash And Equivalents Q3 2018 · Aug 31, 2017 $60.54K
Cash And Equivalents Q3 2018 · Nov 30, 2016 $10.84K
Stockholders Equity Q3 2018 · Aug 31, 2018 −$1.2M
Stockholders Equity Q3 2018 · Nov 30, 2017 −$905.82K
Total Liabilities Q3 2018 · Aug 31, 2018 $1.46M
Total Liabilities Q3 2018 · Nov 30, 2017 $1.01M
Current Assets Q3 2018 · Aug 31, 2018 $209.77K
Current Assets Q3 2018 · Nov 30, 2017 $61.92K
Total Assets Q3 2018 · Aug 31, 2018 $247.66K
Total Assets Q3 2018 · Nov 30, 2017 $107.98K
Sga Expense Q3 2018 · Aug 31, 2018 $19.52K
Sga Expense Q3 2018 · Aug 31, 2018 $164.85K
Sga Expense Q3 2018 · Aug 31, 2017 $28.82K
Sga Expense Q3 2018 · Aug 31, 2017 $54.08K
Net Income Q3 2018 · Aug 31, 2018 −$711.7K
Net Income Q3 2018 · Aug 31, 2018 −$1.69M
Net Income Q3 2018 · Aug 31, 2017 −$695.19K
Net Income Q3 2018 · Aug 31, 2017 −$1.1M
Gross Profit Q3 2018 · Aug 31, 2018 $0
Gross Profit Q3 2018 · Aug 31, 2018 $1.46K
Gross Profit Q3 2018 · Aug 31, 2017 $0
Gross Profit Q3 2018 · Aug 31, 2017 $0
Cost Of Revenue Q3 2018 · Aug 31, 2018 $0
Cost Of Revenue Q3 2018 · Aug 31, 2018 $3.22K
Cost Of Revenue Q3 2018 · Aug 31, 2017 $0
Cost Of Revenue Q3 2018 · Aug 31, 2017 $0
Revenue Q3 2018 · Aug 31, 2018 $0
Revenue Q3 2018 · Aug 31, 2018 $4.68K
Revenue Q3 2018 · Aug 31, 2017 $0
Revenue Q3 2018 · Aug 31, 2017 $0